Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
    • Publication Information:
      Publication: 1995- : New York, NY : Wiley-Liss
      Original Publication: 1966-1984 : Genève : International Union Against Cancer
    • Subject Terms:
      ADAM Proteins/*genetics ; Carcinoma/*genetics ; Lymph Nodes/*pathology ; Nasopharyngeal Neoplasms/*genetics; ADAMTS9 Protein ; Adult ; Aged ; Biomarkers, Tumor/genetics ; Carcinoma/secondary ; Chromosomes, Human, Pair 3 ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Gene Silencing ; Genotype ; Humans ; Immunohistochemistry ; Lymphatic Metastasis ; Male ; Microarray Analysis ; Microsatellite Repeats ; Middle Aged ; Nasopharyngeal Neoplasms/pathology ; Reverse Transcriptase Polymerase Chain Reaction
    • Abstract:
      By using a functional complementation approach, suppression of tumorigenicity was observed after transfer of intact or truncated copies of chromosome 3 into a nasopharyngeal carcinoma (NPC) HONE1 cell line. The extra exogenous chromosome 3 in the microcell hybrids (MCHs) significantly extended the lag period of tumor formation, which may be associated with loss or inactivation of wild type alleles from the normal donor chromosome 3. Representative tumors, which grew in nude mice were reconstituted into culture and expanded as tumor segregants (TSs). In our study, a disintegrin-like and metalloprotease with thrombospondin type 1 motif 9 (ADAMTS9), a gene mapping to 3p14.2, was identified to be critically associated with tumor suppression in NPC. Gene expression analysis showed that ADAMTS9 was either not expressed or was downregulated in HONE1 cells, TSs and NPC cell lines. The mechanism of ADAMTS9 gene inactivation in the NPC cell lines and tissues was attributed to promoter hypermethylation. Using a tissue microarray and immunohistochemical staining, 31 of 66 (47%) of the NPC cases showed downregulated or absence of ADAMTS9 expression. ADAMTS9 expression was downregulated or lost in 17 of 23 (73.9%) lymph node metastatic NPC specimens, which was significantly higher than in 14 of 43 (32.6%) primary tumors. After transfection of the ADAMTS9 gene into 7 NPC cell lines, a dramatic reduction of colony forming ability was observed. These findings support ADAMTS9 as a putative tumor suppressor gene in vivo in NPC that is significantly associated with lymph node metastases.
      ((c) 2008 Wiley-Liss, Inc.)
    • Comments:
      Expression of concern in: Int J Cancer. 2017 Dec 1;141(11):2368. doi: 10.1002/ijc.31032. (PMID: 32872707)
    • Grant Information:
      AR49930 United States AR NIAMS NIH HHS
    • Accession Number:
      0 (Biomarkers, Tumor)
      EC 3.4.24.- (ADAM Proteins)
      EC 3.4.24.- (ADAMTS9 Protein)
      EC 3.4.24.- (ADAMTS9 protein, human)
    • Publication Date:
      Date Created: 20080502 Date Completed: 20080613 Latest Revision: 20220330
    • Publication Date:
      20250114
    • Accession Number:
      10.1002/ijc.23528
    • Accession Number:
      18449890